Ocular Therapeutix, Inc
OCUL- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001393434
In the last 90 days, Ocular Therapeutix, Inc insiders filed 0 open-market purchases and 5 sales; 262 institutions reported holding it in 13F filings for Q2 2026, worth $2.03B in total; no superinvestor holds it.
Q3 2023 vs. Q2 2023
How the institutions holding Ocular Therapeutix, Inc changed between Q2 2023 and Q3 2023.
All holders in Q3 2023All holders in Q2 2023
| Measure | Q2 2023 | Q3 2023 | Change |
|---|---|---|---|
| Holders | 135 | 114 | −21 |
| Shares | 43.5M | 40.4M | −3.04M (−7.0%) |
| Value | $224.2M | $127.0M | −$97.2M (−43.4%) |
New holders (9)
Institutions that held Ocular Therapeutix, Inc at the end of Q3 2023 but not at the end of Q2 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Polar Asset Management Partners Inc. | 263,763 | $828.2K | 0.02% |
| ExodusPoint Capital Management, LP | 98,422 | $309.0K | 0.00% |
| Graham Capital Management, L.P. | 95,363 | $299.4K | 0.01% |
| Man Group plc | – | $50.3K | 0.00% |
| SG Americas Securities, LLC | 12,242 | $38.0K | 0.00% |
| Rafferty Asset Management, LLC | 11,837 | $37.2K | 0.00% |
| Group One Trading, L.P. | 8,280 | $26.0K | 0.00% |
| Stephens Consulting, LLC | 4,000 | $12.6K | 0.01% |
| Belvedere Trading LLC | 1,257 | $3.95K | 0.00% |
Sold out (30)
Institutions that held Ocular Therapeutix, Inc at the end of Q2 2023 and filed for Q3 2023 without it.